← Eichor
Study identifier: NCT07017998 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

External Therapy for Tinnitus Management

Condition: Tinnitus · Tinnitus, Subjective  ·  Sponsor: Restorear Devices LLC

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

The goal of this remote interventional clinical study is to investigate the use of mild therapeutic hypothermia devices for the symptomatic relief of chronic tinnitus. The main aims of the study are: 1. Ascertain the effects of MTH in chronic tinnitus patients using questionnaires measuring tinnitus severity and intervention-related change. 2. Ascertain the comfort and acceptability of the hypothermia device and therapy. Participants with chronic tinnitus will wear the mild therapeutic hypothermia therapy devices for a single 30 minute session. Researchers will compare results from those receiving therapy to those from a control group.

This description comes directly from the study's public registry record.

Talk to the study team

Kendall Stern, MPH  ·  2068187219  ·  kendall.stern@restorear.com

Suhrud Rajguru, PhD  ·  (801) 641-8180  ·  srajguru@restorear.com

Always discuss trial participation with your own doctor first.

Locations (1)

RestorEar DevicesBozeman, Montana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07017998